Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Interactions between platelets, leukocytes, and activated endothelial cells are important during microvascular occlusion; however, the regulatory mechanisms of these heterotypic cell-cell interactions remain unclear. Here, using intravital microscopy to evaluate mice lacking specific isoforms of the serine/threonine kinase AKT and bone marrow chimeras, we found that hematopoietic cell-associated AKT2 is important for neutrophil adhesion and crawling and neutrophil-platelet interactions on activated endothelial cells during TNF-α-induced venular inflammation. Studies with an AKT2-specific inhibitor and cells isolated from WT and Akt KO mice revealed that platelet- and neutrophil-associated AKT2 regulates heterotypic neutrophil-platelet aggregation under shear conditions. In particular, neutrophil AKT2 was critical for membrane translocation of αMβ2 integrin, β2-talin1 interaction, and intracellular Ca2+ mobilization. We found that the basal phosphorylation levels of AKT isoforms were markedly increased in neutrophils and platelets isolated from patients with sickle cell disease (SCD), an inherited hematological disorder associated with vascular inflammation and occlusion. AKT2 inhibition reduced heterotypic aggregation of neutrophils and platelets isolated from SCD patients and diminished neutrophil adhesion and neutrophil-platelet aggregation in SCD mice, thereby improving blood flow rates. Our results provide evidence that neutrophil AKT2 regulates αMβ2 integrin function and suggest that AKT2 is important for neutrophil recruitment and neutrophil-platelet interactions under thromboinflammatory conditions such as SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467 · cited 1×
“Consistent with a previous report (31), 20%–30% of sickle cells were observed in smears of Berkeley mouse blood (Figure 8A).”
GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice
Chang, J., Patton, J. T., Sarkar, A., Ernst, B., Magnani, J. L., & Frenette, P. S. (2010) · Blood · doi:10.1182/blood-2009-12-260513 · Cited by 238 · cited 1×
“Vaso-occlusion induced by sickle red cell-leukocyte-platelet-endothelial cell heterotypic aggregation was abrogated by treatment with a selectin inhibitor in Berkeley mice (46).”
Ischaemic stroke: a thrombo‐inflammatory disease?
Nieswandt, B., Kleinschnitz, C., & Stoll, G. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212886 · Cited by 192 · cited 3×
“Discussion Interaction of activated platelets and leukocytes on the activated vascular endothelium has been recognized as a critical determinant of thromboinflammatory disease (1, 2).”
Akt3 Deficiency in Macrophages Promotes Foam Cell Formation and Atherosclerosis in Mice
Ding, L., Biswas, S., Morton, R. E., Smith, J. D., Hay, N., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.020 · Cited by 83 · cited 1×
“Recent studies have shown that macrophage AKT3 plays a protective role in atherosclerosis (20).”
Self-citation
Research works printed but not linked: 49
- 10.1182/blood-2008-01-078204 · DOI · Paper page
- 10.1080/10739680802350104 · DOI · Paper page
- 10.1038/nm.2514 · DOI · Paper page
- 10.1038/nm.1939 · DOI · Paper page
- 10.1189/jlb.0405193 · DOI
- Wang, 2005, Circulation., 112, 2993, 10.1161/CIRCULATIONAHA.105.571315 · DOI · Paper page
- 10.1084/jem.192.2.193 · DOI · Paper page
- 10.1016/j.blre.2006.06.001 · DOI · Paper page
- 10.1016/j.cellsig.2011.05.004 · DOI · Paper page
- Yang, 2010, Cell Cycle., 9, 487
- 10.1586/ehm.09.75 · DOI
- 10.1182/blood-2003-10-3428 · DOI · Paper page
- 10.1172/JCI200420267 · DOI · Paper page
- 10.1182/blood-2010-12-323204 · DOI
- 10.1182/blood-2009-02-202614 · DOI
- 10.1182/blood-2009-11-255323 · DOI · Paper page
- 10.1073/pnas.0904073106 · DOI · Paper page
- 10.1016/j.cmet.2007.10.007 · DOI · Paper page
- 10.1073/pnas.0906074106 · DOI
- 10.1016/j.bmcl.2007.11.015 · DOI
- 10.1161/01.CIR.98.9.873 · DOI
- Maugeri, 2005, Haematologica., 90, 833
- Evangelista, 1996, Blood., 88, 4183, 10.1182/blood.V88.11.4183.4183 · DOI · Paper page
- Davenpeck, 2000, J Immunol., 165, 2764, 10.4049/jimmunol.165.5.2764 · DOI
- 10.1172/JCI116724 · DOI · Paper page
- Ye, 2011, J Thromb Haemost., 9, 20, 10.1111/j.1538-7836.2011.04355.x · DOI
- Lu, 2011, J Cardiovasc Pharmacol., 58, 439, 10.1097/FJC.0b013e318228e68c · DOI
- 10.1172/JCI30920 · DOI · Paper page
- Borregaard, 1994, J Leuk Biol., 56, 80, 10.1002/jlb.56.1.80 · DOI · Paper page
- Nanamori, 2007, J Immunol., 178, 416, 10.4049/jimmunol.178.1.416 · DOI
- 10.1126/science.287.5455.1037 · DOI · Paper page
- 10.1080/0953710021000024367 · doi:10.1080/0953710021000024367
- Caron, 2002, J Cardiovasc Pharmacol., 40, 296, 10.1097/00005344-200208000-00015 · doi:10.1097/00005344-200208000-00015
- 10.1161/CIRCULATIONAHA.107.691279 · DOI · Paper page
- 10.1161/STROKEAHA.106.476648 · DOI · Paper page
- 10.1161/STROKEAHA.111.000502 · DOI · Paper page
- 10.1182/blood-2012-11-467985 · DOI
- 10.1016/j.ceb.2003.08.003 · DOI · Paper page
- 10.1038/nm.1921 · DOI · Paper page
- 10.1091/mbc.E06-09-0813 · DOI · Paper page
- Marchi, 2008, Biochem Biophys Res Commun., 375, 501, 10.1016/j.bbrc.2008.07.153 · DOI · Paper page
- 10.1146/annurev.immunol.021908.132550 · DOI · Paper page
- 10.1126/science.292.5522.1728 · DOI · Paper page
- 10.1128/MCB.01792-08 · DOI
- 10.1016/0735-1097(96)00164-7 · DOI · Paper page
- 10.1101/gad.913901 · DOI · Paper page
- 10.1101/gad.1089403 · DOI · Paper page
- 10.1073/pnas.050582097 · DOI · Paper page
- 10.3791/50329 · DOI
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
“At the molecular level, the serine/threonine kinase isoform AKT2 in neutrophils appears essential for neutrophil crawling and neutrophil-platelet interactions on activated endothelial cellsduringvascular inflammation.(50) Inhibitionof AKT2 diminishes neutrophil adhesion and neutrophil-platelet interactions, leading to…”
BackgroundLung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Bennewitz, M. F., Jimenez, M. A., Vats, R., Tutuncuoglu, E., Jonassaint, J., Kato, G. J., Gladwin, M. T., & Sundd, P. (2017) · JCI Insight · doi:10.1172/jci.insight.89761 · Cited by 139
Metadata
- Authors
- Li, J., Kim, K., Hahm, E., Molokie, R., Hay, N., Gordeuk, V. R., Du, X., & Cho, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1483-1496
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2114267611
- Cited by
- 69
- References
- 4
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.